Newsroom
Latest News
Members of Congress from both parties expressed immense frustration on Wednesday at big increases in insulin prices and vowed to work together on legislation to prevent more people from dying because they could not afford the lifesaving medicine.
Representative Earl L. Carter, Republican of Georgia, said at the end of a three-hour hearing with pharmaceutical executives and middlemen, known as pharmacy benefit managers, "You've done something here today that we've been trying to do in Congress for years, and that is to create bipartisanship."
U.S. Rep. Diana DeGette threatened pharmaceutical company executives with government intervention Wednesday during a congressional hearing into the rising price of insulin.
"I think we can all agree that the system is broken," DeGette, D-Denver, said about the method the companies use to set their insulin prices.
DeGette, a Denver Democrat, is chairwoman of the House Energy and Commerce subcommittee on oversight and investigations, which held the hearing.
Insulin is a hormone produced by the pancreas that helps lower the body's glucose, or sugar, levels in the blood.
"We believe it is necessary to the goal of collecting actual emissions data and working with real numbers, rather than models or estimates." Brian Cain, Extraction Oil and Gas spokesman
Colorado public health officials have let oil and gas companies begin drilling and fracking for fossil fuels at nearly 200 industrial sites across the state without first obtaining federally required permits that limit how much toxic pollution they can spew into the air.
Colorado public health officials routinely allow oil and gas companies to begin drilling and fracking without obtaining federally required permits that limit the amount of pollution they can discharge into the air.
The state Department of Public Health and Environment allows companies to release emissions without permits under a decades-old exemption that gives a 90-day window, the Denver Post reported Sunday.
WASHINGTON, D.C. – U.S. Reps. Diana DeGette (D-CO) and Jackie Speier (D-CA) introduced legislation today to overhaul the U.S. military's policy on providing servicemembers and their families with family-planning counseling services and coverage for contraceptives.
The bill would require the Department of Defense to provide all women who receive health care through the military's health insurance program access to all forms of FDA-approved contraception without any co-pay.
WASHINGTON, D.C. – U.S. Reps. Diana DeGette (D-CO), Mark DeSaulnier (D-CA), Zoe Lofgren (D-CA) and Jamie Raskin (D-MD) introduced a resolution today to recognize the vital role that local journalists play in promoting good governance and accountability.
WASHINGTON, D.C. – U.S. Rep. Diana DeGette (D-CO), chair of the House oversight panel that's investigating the skyrocketing cost of insulin, announced today that all three U.S. manufacturers of insulin will be appearing before Congress next week.
The only three companies that manufacture insulin in the United States will testify in the House next week about their pricing practices.
Rep. Diana DeGette (D-Colo.), chairwoman of the House Energy and Commerce oversight subcommittee, said the three companies— Eli Lilly, Novo Nordisk and Sanofi— will testify April 10.
"We want to know why the cost of this life-saving drug has skyrocketed in recent years, and why they're not offering more lower-cost alternatives to patients," DeGette said.
U.S. Representative Diana DeGette's bill to halt federal marijuana prohibition in states where cannabis is legal was introduced on Monday, April 1, but she insists the issue is no joke.